Authors and Disclosures
Eric Dumonteil‡
Laboratorio de Parasitología Centro De Investigaciones Regional, "Dr. Hideo Noguchi" Autonomous University of Yucatan (UADY), Merida, Mexico
Maria Elena Bottazzi‡
Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics (Section of Pediatric Tropical Medicine) and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA
Bin Zhan
Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics (Section of Pediatric Tropical Medicine), National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA
Michael J Heffernan
Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics (Section of Pediatric Tropical Medicine), National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA
Kathryn Jones
Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics (Section of Pediatric Tropical Medicine) and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA
Jesus G Valenzuela
Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA
Shaden Kamhawi
Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA
Jaime Ortega
Departamento de Biotecnologéa y Bioingeniería, Centro de Investigacion y de Estudios Avanzados - Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City, Mexico
Samuel Ponce de Leon Rosales
Laboratorios de Biológicos y Reactivos de México (BIRMEX), Mexico City, Mexico
Bruce Y Lee
Public Health Computational and Operations Research (PHICOR), University of Pittsburgh, Pittsburgh PA, USA
Kristina M Bacon
Public Health Computational and Operations Research (PHICOR), University of Pittsburgh, Pittsburgh PA, USA
Bernhard Fleischer
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
BT Slingsby
Eisai Co., Ltd, Tokyo, Japan
Miguel Betancourt Cravioto
Instituto Carlos Slim de la Salud (ICSS), Mexico City, Mexico
Roberto Tapia-Conyer
Instituto Carlos Slim de la Salud (ICSS), Mexico City, Mexico
Peter J Hotez*‡
Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics (Section of Pediatric Tropical Medicine) and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA
Financial & competing interests disclosure
Michael Heffernan is a co-inventor on three patent applications pertaining to the pH-sensitive microparticles discussed in this manuscript. Several of the authors are involved in various aspects of the development and possible future manufacture of a potential vaccine currently in development against Chagas disease. The Carlos Slim Institute of Health and the Southwest Electronic Energy Medical Research Institute are providing financial support for the Chagas disease vaccine initiative. Eisai Co., Ltd is providing access to the E6020 adjuvant. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
*Author for correspondence
hotez@bcm.edu
‡Authors contributed equally to this manuscript.